Singapore firm invests Rs 155 cr in Indiabulls' pharma business
The company does not have its own manufacturing unit and outsources products
 "Singapore firm invests Rs 155 cr in Indiabulls' pharma business")
premium
Singapore-based investment firm Clermont Group has invested Rs 155 crore in Indiabulls Group's pharmaceutical business. Indiabulls Group, which has interests in real estate and housing finance, had set up a pharmaceutical sales and distributions firm last year.
"We began sales in May and in six months we have done a turnover of around Rs 70 crore. We have products across therapies and our focus is on domestic market. We will use the fresh capital to grow our business," said Nikhil Chari, CEO of Indiabulls Pharmaceuticals.
The company does not have its own manufacturing unit and outsources products.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%